Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Newsbot!
    Banned
    • Feb 2008
    • 1331

    #1

    ChIP-Seq: A fully Bayesian hidden Ising model for ChIP-seq data analysis.

    Syndicated from PubMed RSS Feeds

    A fully Bayesian hidden Ising model for ChIP-seq data analysis.

    Biostatistics. 2011 Sep 13;

    Authors: Mo Q

    Abstract
    Chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) is a powerful technique that is being used in a wide range of biological studies including genome-wide measurements of protein-DNA interactions, DNA methylation, and histone modifications. The vast amount of data and biases introduced by sequencing and/or genome mapping pose new challenges and call for effective methods and fast computer programs for statistical analysis. To systematically model ChIP-seq data, we build a dynamic signal profile for each chromosome and then model the profile using a fully Bayesian hidden Ising model. The proposed model naturally takes into account spatial dependency and global and local distributions of sequence tags. It can be used for one-sample and two-sample analyses. Through model diagnosis, the proposed method can detect falsely enriched regions caused by sequencing and/or mapping errors, which is usually not offered by the existing hypothesis-testing-based methods. The proposed method is illustrated using 3 transcription factor (TF) ChIP-seq data sets and 2 mixed ChIP-seq data sets and compared with 4 popular and/or well-documented methods: MACS, CisGenome, BayesPeak, and SISSRs. The results indicate that the proposed method achieves equivalent or higher sensitivity and spatial resolution in detecting TF binding sites with false discovery rate at a much lower level.


    PMID: 21914728 [PubMed - as supplied by publisher]



    More...

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...